Ofer Daphna News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ofer daphna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ofer Daphna Today - Breaking & Trending Today
EyeYon Medical Receives CE Mark for its EndoArt® Implant to Treat Chronic Corneal Edema Font : A-A+ EndoArt® previously received Innovative Device Status by the Chinese NMPA, and Breakthrough Device Designation from the US Food and Drug Administration TEL AVIV, Israel, June 8, 2021 /PRNewswire/ EyeYon Medical, an Israeli start-up company developing a variety of ophthalmic products for vision-threatening conditions, announced today that it has received CE Mark for its EndoArt®, after clinical trials demonstrated safety and efficacy for treating chronic corneal edema. The CE Mark serves as approval by the European Union (EU) to commercialize EndoArt®, the world s first and only synthetic implant, which replaces the human endothelium that the human body can never regenerate. The current standard of care involves corneal transplantation of human tissue. This unique implant enables doctors to treat endothelial-related chronic corneal edema with a minimally ....
Israeli cornea treatment co EyeYon raises $25m The Israeli company will use the capital to expand clinical trials to treat corneal endema. Israeli medical device company EyeYon Medical EyeYon Medical today announced the completion of a $25 million Series C financing round, led by a global strategic leader in the ophthalmic industry and CR-CP Life Science Fund, together with Global Health Sciences (GHS) Fund (Quark Venture LP and GF Securities), BPC and existing investors Triventures, Rimonci, Pontifax and Diamond BioFund. The latest round brings the total amount of capital raised by the company to $36 million. EyeYon Medical, which was founded in 2011 by Dr. Ofer Daphna, CEO Nahum Ferera, and Dr. Arie Marcovich, develops advanced technology to treat acute ophthalmic problems. ....
EyeYon Medical Raises $25 million in Series C to Transform Corneal Care USA - English News provided by Share this article Share this article TEL AVIV, Israel, March 15, 2021 /PRNewswire/ EyeYon Medical announced today the completion of a $25 million in a Series C funding, led by a global strategic leader in the ophthalmic industry and CR-CP Life Science Fund. Other participants in the round include Global Health Sciences (GHS) Fund (Quark Venture LP and GF Securities), BPC and existing investors Triventures, Rimonci, Pontifax and Diamond BioFund. EyeYon Medical was founded in 2011 by Dr. Ofer Daphna, CEO Nahum Ferera MD, and Dr. Arie Marcovich, MD., and develops advanced technology to treat acute problems in the ophthalmic world. The latest round brings the total amount of capital raised by the company to $36 million. ....
Israeli startup EyeYon Medical completes $25M Series C round mobihealthnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mobihealthnews.com Daily Mail and Mail on Sunday newspapers.